Literature DB >> 12951642

Glucosensing neurons in the ventromedial hypothalamic nucleus (VMN) and hypoglycemia-associated autonomic failure (HAAF).

Vanessa H Routh1.   

Abstract

Hypoglycemia is a profound threat to the brain since glucose is its preferred fuel. Thus, decreases in plasma glucose must be sensed and appropriate hormonal and neuroendocrine responses generated to restore glucose to safe levels (i.e. counterregulatory responses (CRR) to hypoglycemia). Recurrent hypoglycemia impairs these protective mechanisms, resulting in a potentially life-threatening condition known as hypoglycemia-associated autonomic failure (HAAF). During HAAF, the glycemic threshold is reset so that glucose levels must fall further before the CRR is initiated. The brain plays a critical role in sensing hypoglycemia and initiating the CRR. Additionally, many neurons may sense changes in plasma and extracellular glucose. However, the way in which central glucose sensing is integrated to lead to effective initiation of the CRR is unknown. Furthermore, the mechanisms by which this system becomes impaired during HAAF are also unknown. Glucosensing neurons in the ventromedial hypothalamic nucleus (VMN) are poised to serve an integrative function in glucose homeostasis. First, they sense glucose. Second, the VMN receives input from other glucose-sensing areas. Finally, the VMN projects to areas linked to the regulation of the sympathoadrenal system that mediates the CRR. This review discusses VMN glucosensing neurons relative to their capacity to play a role in the regulation of the CRR and the generation of HAAF. Glucosensing neurons in the hindbrain as well as peripheral glucosensors are also considered. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12951642     DOI: 10.1002/dmrr.404

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  21 in total

Review 1.  Multiple hypothalamic circuits sense and regulate glucose levels.

Authors:  Mahesh Karnani; Denis Burdakov
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-03       Impact factor: 3.619

2.  Hypothalamic Glucose Transport in Humans During Experimentally Induced Hypoglycemia-Associated Autonomic Failure.

Authors:  Elizabeth R Seaquist; Amir Moheet; Anjali Kumar; Dinesh K Deelchand; Melissa Terpstra; Kristine Kubisiak; Lynn E Eberly; Pierre-Gilles Henry; James M Joers; Gülin Öz
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

3.  Effect of chronic hypoglycaemia on glucose concentration and glycogen content in rat brain: A localized 13C NMR study.

Authors:  Hongxia Lei; Rolf Gruetter
Journal:  J Neurochem       Date:  2006-10       Impact factor: 5.372

4.  Alterations in blood glucose levels under hyperinsulinemia affect accumbens dopamine.

Authors:  Nicholas T Bello; Andras Hajnal
Journal:  Physiol Behav       Date:  2006-05-05

5.  Glucose prevents the fall in ventromedial hypothalamic GABA that is required for full activation of glucose counterregulatory responses during hypoglycemia.

Authors:  Wanling Zhu; Daniel Czyzyk; Sachin A Paranjape; Ligang Zhou; Adam Horblitt; Gábor Szabó; Margretta R Seashore; Robert S Sherwin; Owen Chan
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-02-09       Impact factor: 4.310

6.  Injection of Urocortin 3 into the ventromedial hypothalamus modulates feeding, blood glucose levels, and hypothalamic POMC gene expression but not the HPA axis.

Authors:  Peilin Chen; Joan Vaughan; Cindy Donaldson; Wylie Vale; Chien Li
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-01       Impact factor: 4.310

7.  Initial experience with seven tesla magnetic resonance spectroscopy of hypothalamic GABA during hyperinsulinemic euglycemia and hypoglycemia in healthy humans.

Authors:  A Moheet; U E Emir; M Terpstra; A Kumar; L E Eberly; E R Seaquist; G Öz
Journal:  Magn Reson Med       Date:  2013-02-19       Impact factor: 4.668

8.  Hypothalamic ventromedial COUP-TFII protects against hypoglycemia-associated autonomic failure.

Authors:  Lina Sabra-Makke; Micol Maritan; Julien Planchais; Marie Boutant; Jean-Paul Pégorier; Patrick C Even; Mireille Vasseur-Cognet; Pascale Bossard
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

9.  Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes.

Authors:  X Fan; Y Ding; S Brown; L Zhou; M Shaw; M C Vella; H Cheng; E C McNay; R S Sherwin; R J McCrimmon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-04-08       Impact factor: 3.619

10.  Rapid-onset hypoglycemia suppresses Fos expression in discrete parts of the ventromedial nucleus of the hypothalamus.

Authors:  Nicholas N Foster; Sana Azam; Alan G Watts
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-03-30       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.